During a special online presentation—broadcast on April 28, 2020 at 11 am EDT—the editors of Pharmaceutical Technology and BioPharm International interview experts who will discuss approaches that are helping manufacturers surmount these challenges, while technology providers and representatives from different facets of the pharma industry—regulatory, contract testing and manufacturing, quality control, and distribution—will share best practices that are enabling them to meet the pandemic’s challenges head on.
Topics to be discussed in this Editors’ Series event, Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times, include the following:
- Business continuity best practices
- Employee and facility safety
- Regulatory compliance
- Addressing deviations
- Testing guidance for new and existing drugs
- Supplier oversight
- Supply chain challenges
- Data security, data integrity, and remote data access and collaboration.
Invited speakers:
- Steve Goldman, consultant, Steve Goldman Associates
- David Light, CEO, Valisure
- Susan Schniepp, distinguished fellow, Regulatory Compliance Associates
- Jaap Venema, executive vice president and chief science officer, United States Pharmacopeia
- Mary Blenn, vice-president global supply chain, Cytiva
- Angelo Stracquatanio, CEO, apprentice.io
- Lisia Marina Scholz Dias, lead application engineer, Applied Materials
The webcast is organized by Pharmaceutical Technology and BioPharm International magazines, in conjunction with the INTERPHEX trade show.
